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Objectives: To assess longitudinally small airway function in children born extremely 
prematurely and whether there was a correlation between airway function in infancy and at 
11 to 14 years.     
Working hypotheses:  There would be tracking of airways obstruction and small airway 
function would deteriorate during childhood in those born extremely prematurely. 
Study design:  A longitudinal study.  
Patient –subject selection: Thirty-five children with a mean gestational age of 26 weeks had 
lung function assessed at one year corrected and 11-14 years of age.  
Methodology:  Lung volumes were measured by helium gas dilution (FRCHe) and 
plethysmography (FRCpleth) and small airway function assessed by calculating the 
FRCHe:FRCpleth ratio. Airway function was assessed at one year corrected by measurement of 
airway resistance (Raw) and at 11-14 years by assessment of Raw, forced expiratory flow from 
75% of vital capacity (FEF75) and forced expiratory volume at one second (FEV1). 
Results:  At the first assessment, the children had a mean (SD) FRCHe: FRCpleth of 0.90 (0.13) 
and at the second, 0.83 (0.12) (p= 0.035). There was a significant 0.54% decrease (95% CI: -
1.02%, -0.06%) in FRCHe: FRCpleth for increased age per year after adjusting for birth weight, 
gestational age, sex and bronchopulmonary dysplasia (p=0.027). There were significant 
correlations between Raw at the first assessment and Raw (p=0.012), FEF75 (p=0.034) and 
FEV1 (p=0.04) at 11-14 years. 
Conclusions:  These results demonstrate in those born extremely prematurely there is 





Prematurely born infants frequently suffer troublesome respiratory symptoms and lung 
function abnormalities in the first two years after birth. Adolescents 1-5 and adults 6-8 born 
very prematurely have been reported to have airways obstruction and impaired exercise 
tolerance. Small airway function appears to deteriorate during infancy 9, 10.  It is not, however, 
clear whether there are changes in airway obstruction with increased age in older children, as 
there have been few longitudinal studies and their results conflicting. Certain studies have 
shown that lung function tracked with increasing age 11, 12, whereas another documented 
airways obstruction at 7-9 years of age but not at 21 years 13. In the latter study, however the 
subjects were relatively mature at birth, their mean gestational age being 31.5 weeks.  In 
contrast, amongst young people born very low birth weight (VLBW) who developed BPD, 
airway obstruction worsened between 8 and 18 years 14. In addition, amongst 87 extremely 
low birth weight (ELBW) survivors lung function significantly deteriorated between eight 
and twelve years (FEV1 from 83 to 77% expressed as the percent predicted for age, height 
and sex and FEV1/FVC from 84% to 78%); the deterioration was independent of the 
diagnosis of BPD 15.   Whether there are changes in lung function during childhood in those 
born extremely prematurely and routinely exposed to antenatal corticosteroids and postnatal 
surfactant remains to be determined.  
 
The United Kingdom Oscillation Study recruited infants born less than 29 weeks of 
gestational age 16. More than 90% of the infants were exposed to antenatal steroids and 
postnatal surfactant, hence their results are generalisable to the current, extremely 
prematurely born population. A subset had measurements at a corrected age of one year of 
lung volumes by plethysmography (FRCpleth) and helium gas dilution (FRCHe) and airways 
resistance (Raw) was also assessed 
17. The FRCHe:FRCpleth ratio was calculated to assess small 
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airway function. The children were reassessed at 11 to 14 years of age with detailed lung 
function assessments 18. Our aim was to compare determine if there was a correlation 
between airway function at a corrected age of one year and at 11-14 years of age and 
determine if in those children, with paired FRCHe: FRCpleth results, there had been 
deterioration in small airway function.   
 
PATIENTS AND METHODS 
The children included in this study had been recruited into the United Kingdom Oscillation 
Study (UKOS) 16. Infants were randomised to their initial mode of ventilation (high 
frequency oscillatory ventilation or conventional mechanical ventilation) in the first hour 
after birth. The initial lung function and follow up study were approved by the South Thames 
Multicentre Research Ethics Committee and the South West London National Research 
Ethics Service Committee respectively. All parents gave informed written consent. All 
assessments were made in the Amanda Smith infant and paediatric respiratory laboratories at 
King’s College Hospital NHS Foundation Trust and performed according to guidelines from 
the American Thoracic Society and the European Respiratory Society. On arrival, a history 
was taken and the subject weighed, measured and examined. Appointments were deferred for 
two weeks if the subject had a respiratory tract infection.  
 
Assessment at one year corrected age  
The full details of the respiratory function assessments are reported elsewhere 17. In brief, all 
UKOS babies whose families lived in London were invited to attend King’s College Hospital 
in South London to participate in this study. Infants were sedated with 80-120 mg/kg of 
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chloral hydrate and monitored by pulse oximetry (Datex, Ohmeda 3800, Hatfield, UK). The 
testing procedure consisted of measurement of FRC by plethysmography (FRCpleth) 
(Department of Medical Engineering, Hammersmith Hospital, London), FRC by helium 
dilution (FRCHe) (Equilibrated BioSystems, New York, USA) and airways resistance by 
plethysmography (Raw). The results are expressed as the absolute values and as the 
percentage predicted for length FRCpleth and FRCHe
19. The FRCHe: FRCpleth ratio was 
calculated.  
 
Assessment at 11-14 years  
Full details of the respiratory measurements are reported elsewhere 18. In brief, lung volumes 
were assessed by measuring functional residual capacity using a helium-dilution technique 
(FRCHe) and by plethysmography (FRCpleth).  All measurements were undertaken using a 
Jaeger Masterscreen PFT system (Carefusion Ltd, Basingstone, UK). Two measurements 
within 5% of each other were averaged to calculate the final result 20-22. The FRCHe:FRCpleth 
ratio was  calculated.  Small-airway function was also assessed by measurement of forced 
expiratory flow at 75% of the expired vital capacity (FEF75) by spirometry. In addition, 
airway function was assessed by spirometric measurement of forced expiratory volume in one 
second (FEV1), and plethsymographic assessment of Raw. The absolute lung volumes are 
presented and all lung-function results are also expressed as the percentage predicted for 
height 23, 24.  Exposure to tobacco was estimated using urinary cotinine. A cotinine level of 
less than 10 ng per millilitre was defined as undetectable, a level of 10 to 30 ng per millilitre 
was considered to indicate passive smoking, and a level of more than 30 ng per millilitre was 




Assessment of respiratory health 
At age one year corrected, the infants were seen by their local paediatricians who, with the 
parents, completed a respiratory questionnaire 26. The parents were asked if their infant 
wheezed, had received any medicines for chest problems in the previous 12 months or had 
any hospital admissions for breathing difficulties. When the subjects were 11-14 years of age, 
their parents completed a questionnaire which included questions regarding respiratory 
problems prior to their children’s assessment. 
 
Analysis 
The change in lung function (FRCHe: FRCpleth) over time was analysed using mixed models, 
which took into account the length of time between the two assessments for each child. Sex, 
gestational age groups (23-25 weeks, 26-28 weeks in keeping with the stratification at 
randomisation), birth weight and BPD status (BPD36 defined as being oxygen dependent at 36 
weeks PMA), were thought to be likely confounders and were adjusted for in the models. If 
the changes in lung function were significant for each additional year in age, the effect of sex, 
mode of ventilation and BPD status on the degree of change were examined. This was 
conducted by adding an interaction term of time and one of the aforementioned variables into 
the mixed model. If the term had a p-value of <0.05, the effect of the variable was considered 
to be statistically significant. In a sensitivity analysis, oxygen dependency at 28 days was 
used in the model instead of oxygen dependency at 36 weeks PMA. The relationship between 
airway function (Raw) at a corrected age of one year and airway function (Raw, FEF75 and 
FEV1) at 11-14 years was examined by the Pearson correlation or the Spearman correlation 
coefficient as appropriate. Differences in symptom status at each assessment were assessed 





Seventy-six infants had pulmonary function assessments at one year corrected age and 44 of 
those children (58%) had further lung function assessment at age 11 to 14 years. Thirty-five 
children had results for FRCHe and FRCpleth at both assessments and form this study’s cohort 
(Figure 1). Missing measurements at the first assessment were due to not being able to obtain 
technically acceptable recordings or the infant woke before the measurements were complete. 
Missing data at the follow-up assessment were due to the child’s inability to perform the test, 
results not within 10% of each other or severe airways obstruction (FEV1 z score less than or 
equal to -3.5). The study cohort had a lower mean gestational age (p=0.04); and fewer of the 
mothers smoked antenatally (p=0.04) in comparison with those not included, but they were 
otherwise similar with respect to their baseline characteristics (Table 1). Thirteen percent of 
infants had wheezy attacks in the first year after birth and nine per cent had received 
antibiotics (table 1). When cotinine levels were assessed at age 11-14 years, 13% of the 
young people were exposed to passive smoking and 9% likely were active smokers (table 1). 
 
At the first assessment, the children had a mean (SD) FRCHe: FRCpleth of 0.90 (0.13) and at 
the second assessment, 0.83 (0.12) (Table 2) (Figure 2). The lung function changes were then 
adjusted for several factors: sex, gestational age, birth weight and BPD status (BPD36). This 
gave an adjusted mean difference between each child’s assessments of -0.0054, 95% CI -
0.0102 to -0.0006, p=0.027. This difference is equivalent to a decrease of 0.54% (95% CI: -




In addition, we tested the model to see if the change in lung function was moderated by any 
of sex, BPD, mode of ventilation, smoking in pregnancy or passive smoke exposure at age 
11-14. None of the interaction tests were statistically significant: sex (interaction p=0.37), 
BPD36 status (interaction p=0.69), mode of ventilation (interaction p=0.48), smoking in 
pregnancy (interaction p=0.07). Smoking in pregnancy did not appreciably affect the 
estimated mean change over time (0.54% vs 0.55% per year) and similarly passive smoke 
exposure was not significantly related to the change in lung function (p=0.62) and the 
interaction test would not converge. Similarly, the interaction test would not converge for 
active smoking ie was not significant, but only three children were active smokers as defined 
by their cotinine levels. The sensitivity analysis using BPD defined as oxygen dependency at 
28days gave similar results to those above using BPD36weeks.  (data not shown).  
 
There were significant correlations between Raw at the first assessment and Raw (r=0.42, 
p=0.012), FEF75 (r=-0.37, p=0.034) and FEV1 (r=-0.37, p=0.04) at 11 to 14 years.  
 
Questionnaire results of wheeze and use of chest medication were available at both 
assessments for 31 subjects. The number with wheeze had reduced from eight to three 
(p=0.008) and the number who used chest medications from sixteen to three (p<0.001). 
Respiratory hospital admission data were available for 29 subjects and had reduced from 12 







We have demonstrated that airway resistance (Raw) at one year corrected correlated with the 
results at follow-up of Raw, FEF75 and FEV1. The results suggest that airway development 
was impaired. Indeed, at 11-14 years of age the median FEV1 and FEF75 results were at least 
minus one z score based on data from healthy term born children.  Our results are supported 
by previous results.  Extremely preterm infants (gestational ages < 28 weeks) or extremely 
low birth weight (ELBW < 1000 grams) were studied at 8 and 18 years.  They had substantial 
airflow impairments at both age and a greater increase in small airway obstruction.  
Importantly, those who were smokers at 18 years had airway obstruction that increased over 
time compared with those who did not 27.  Similarly, in ELBW children the obstructive 
pattern of lung function deteriorated between 8 to 12 years 28.   
 
A possible explanation for our results is that exposure of the immature lung to the shear stress 
of mechanical ventilation and/or the higher inspired oxygen concentration compared to in 
utero may have affected subsequent airway development. Cyclic stretching of isolated lung 
cells results in production of IL-8 and other inflammatory markers and the magnitude of 
production was related to the degree of stretch 29, 30. An alternative explanation is that 
accelerated maturation resulting from intrauterine stress or antenatal corticosteroid 
administration may have adversely affected airway development. In a non-randomised study, 
fourteen year olds exposed to antenatal steroids compared to those unexposed had a greater 
prevalence of larger airway obstruction (35% versus 21%) and were twice as likely to have 
wheezing in the last 12 months 31. In our study, all of the subjects had been exposed to 
antenatal steroids. Such exposure, however, cannot be the only factor, as in one study 
reporting deterioration of small airway function during infancy, only one of the cohort had 
antenatal steroid exposure 10. A further explanation to be considered is the impact of maternal 
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antenatal smoking and active adolescent smoking. Antenatal smoke exposure is associated 
with a reduction in airway function 32. Parental and active smoking have been demonstrated 
to act synergistically to affect early lung function deficits in young adulthood 33. Thirteen 
percent of mothers in this study smoked antenatally, but neither maternal smoking in 
pregnancy nor passive smoking adversely influenced the change in lung function with time. 
Urinary cotinine analysis indicated that 9% of the young people were likely to have been 
actively smoking at 11 to 14 years of age, but this amounted to only three children and no 
significant effect was shown in the change in lung function. 
  
The mean FRCHe:FRCpleth results were statistically significantly lower at 11-14 years 
compared to one year corrected. This result remained significant after adjusting for birth 
weight, gestational age, sex and BPD36  status. Those results suggest a deterioration in small 
airway function with increasing age in the extremely prematurely born young people, who 
had routinely been exposed to antenatal steroids and postnatal surfactant. Those results 
however should be interpreted with the caveat that although similar techniques were used at 
both assessments, different equipment was used to measure FRCpleth. It has been shown that 
FRC measured by certain commercially available equipment was significantly lower than 
published reference data and lower than data reported for gas dilution techniques34. We, 
however, used a conventional plethysmograph (Department of Medical Engineering, 
Hammersmith Hospital, London,UK) which has been shown to accurately measures volumes 
as assessed using a lung model 35.  The FRCHe :FRCpleth  which assesses the raw data is not 
affected by the differences in the reference ranges. The FRCHe:FRCpleth ratio in infancy was 
similar to that reported in term born infants 36. We did not report our Raw results as z scores 
as there is no one reference range which spans the age range of those included in this 
longitudinal study. Using a reference range which included infants 37 and one which included 
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children aged 2 to 18 years 38, however,suggests that the Raw results adjusted for weight may 
not have changed.  Hence, we suggest the change in airway function we report may be 
specific to small airways.  The reduction in small airway function was not associated with an 
increase in symptoms, indeed, there was a statistically significant reduction in the respiratory 
hospital admission rate. In the first two years, hospitalisation is usually due to lower 
respiratory tract infections often due to respiratory syncytial virus 39 and this becomes less of 
a problem with increasing age.  It is possible, however, that children “live within their lung 
function”.  In one study, lung function was highest in highly physically active children aged 9 
to 10 years 40.  Those results, however, could be interpreted that children with poorer lung 
function exercise less and, therefore, complain of less symptoms.   
 
There are strengths and some limitations of our study. Similar techniques to assess FRCHe 
and FRCpleth were used at both assessments, but at one year the infants were assessed supine, 
whereas at 11 to 14 years the children were assessed while sitting. The latter position would 
have “benefitted” their lung function, because in the supine position the abdominal contents 
would have pressed on the diaphragm reducing lung volume. Hence, we might have expected 
to see a higher FRCHe:FRCpleth ratio, rather than the reverse. We were unable to assess all the 
children assessed at one year at 11 to 14 years, but those reassessed did not differ 
significantly from those UKOS children not included, other than this study cohort were born 
at a shorter mean gestational age and a lower proportion of their mothers had smoked 
antenatally. This suggests our results are generalisable. We did not adjust the lung function 
results for ethnicity, but more than 80% of our subjects were Caucasian. A few of the 
children had FRCHe:FRCpleth ratios that were greater than one (Figure 2), but as each of their 
lung volume results fulfilled the ATS guidelines for reproducibility their data were included 
in the analysis.  We did not report our Raw results as percentage predicted for height as our 
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Ethics Committee did not allow us to sedate healthy term born infants for the purpose of 
creating a reference range.  In this subset, only 10% had wheeze at 11-14 years compared to 
15% in the whole cohort 18, suggesting our sample was not biased by parents seeking further 
assessment for a symptomatic child.    
 
In conclusion, we have demonstrated that tracking occurs in lung function between infancy 
and   11 to 14 years. Our results suggest that there may have been a deterioration in small 
airway function.  Lung function abnormalities in school age children may have important 
functional consequences.  In one study of 9 to 11 year old children, in those born prior to 33 
weeks of gestation, airways obstruction was associated with chest CT abnormalities including 
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Figure 1:  Flow chart for study cohort 
Figure 2:  FRCHe:FRCpleth results at the first and second assessment 
 
TABLE LEGENDS 
Table 1:   Baseline characteristics by inclusion status 
Table 2:   Lung function results (unadjusted) at the initial and second assessment 
 
 
 
